Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double Blind, Placebo Controlled Trial to Determine the Efficacy of Isoniazid (INH) in Preventing Tuberculosis Disease and Latent Tuberculosis Infection Among Infants With Perinatal Exposure to HIV

NCT00080119 is registered in ClinicalTrials.gov with International Maternal Pediatric Adolescent AIDS Clinical Trials Group as lead sponsor.

NCT NCT00080119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00080119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double Blind, Placebo Controlled Trial to Determine the Efficacy of Isoniazid (INH) in Preventing Tuberculosis Disease and Latent Tuberculosis Infection Among Infants With Perinatal Exposure to HIV
Lead sponsor
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Phase
Phase 2/3
Overall status
Terminated
Start date
February 29, 2004
Completion date
May 31, 2009
Enrollment
1,354 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection, pneumocystis jiroveci pneumonia, tuberculosis